» Articles » PMID: 16402912

Function of Retinoid Nuclear Receptors: Lessons from Genetic and Pharmacological Dissections of the Retinoic Acid Signaling Pathway During Mouse Embryogenesis

Overview
Publisher Annual Reviews
Specialties Pharmacology
Toxicology
Date 2006 Jan 13
PMID 16402912
Citations 238
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoic acid (RA) is involved in vertebrate morphogenesis, growth, cellular differentiation, and tissue homeostasis. The use of in vitro systems initially led to the identification of nuclear receptor RXR/RAR heterodimers as possible transducers of the RA signal. To unveil the physiological functions of RARs and RXRs, genetic and pharmacological studies have been performed in the mouse. Together, their results demonstrate that (a) RXR/RAR heterodimers in which RXR is either transcriptionally active or silent are involved in the transduction of the RA signal during prenatal development, (b) specific RXRalpha/RAR heterodimers are required at many distinct stages during early embryogenesis and organogenesis, (c) the physiological role of RA and its receptors cannot be extrapolated from teratogenesis studies using retinoids in excess. Additional cell type-restricted and temporally controlled somatic mutagenesis is required to determine the functions of RARs and RXRs during postnatal life.

Citing Articles

Redefining retinoic acid receptor expression in zebrafish embryos using Hybridization Chain Reaction.

Gray R, Lovely C Differentiation. 2024; 140:100822.

PMID: 39627912 PMC: 11653530. DOI: 10.1016/j.diff.2024.100822.


Nuclear Receptors and the Hidden Language of the Metabolome.

Chen Y, Anderson M, Payne N, Santori F, Ivanova N Cells. 2024; 13(15.

PMID: 39120315 PMC: 11311682. DOI: 10.3390/cells13151284.


Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.

BharathwajChetty B, Sajeev A, Vishwa R, Aswani B, AlQahtani M, Abbas M Cancer Metastasis Rev. 2024; 43(1):321-362.

PMID: 38517618 DOI: 10.1007/s10555-024-10171-0.


Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies.

Ghorayshian A, Danesh M, Mostashari-Rad T, Fassihi A PLoS One. 2023; 18(8):e0289046.

PMID: 37616260 PMC: 10449137. DOI: 10.1371/journal.pone.0289046.


Targeting Retinol-Binding Protein 4 (RBP4) in the Management of Cardiometabolic Diseases.

Oluwamodupe C, Adeleye A Cardiovasc Toxicol. 2023; 23(9-10):285-294.

PMID: 37587250 DOI: 10.1007/s12012-023-09803-8.